Metagenomics approach to predict antibiotic resistance genes in sputum samples of adult people with cystic fibrosis: a pilot study
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.02299-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Sonja van Scheijen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Cystic Fibrosis, Sputum, Metagenomics, Anti-Bacterial Agents. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting TAAI, Longfonds, Stichting Astma Bestrijding.
Abstract (Originalsprache)
Lung infections in people with cystic fibrosis (CF) cause lung damage, which is the leading factor in the morbidity and mortality of CF. Prescription of antibiotics to treat these infections is essential to maintain a higher quality of life and increase life expectancy. Determination of antibiotic susceptibility (ABS) is done by culture-dependent, phenotypic methods. These procedures take several days, while timely intervention is key. The analysis of antibiotic resistance genes by use of shotgun metagenomics might offer a time-sensitive alternative. Twenty people with CF with a homozygous Phe508del mutation provided 68 sputum samples during different visits over a period of roughly a year. After shotgun sequencing, the samples were analyzed using the deep learning tool deepARG. These results were compared with the results from routine ABS testing. The performance was determined by area under the curve-receiver operating characteristics (AUCROC) and sensitivity. Significant results were obtained for the following antibiotic classes: aminoglycoside (AUCROC = 0.81 [95% CI: 0.67–0.95, sensitivity = 73%]), cephalosporin (AUCROC = 0.70 [95% CI: 0.54–0.86, sensitivity = 95%]), and fluoroquinolone (AUCROC = 0.73 [95% CI: 0.56–0.89, sensitivity = 88%]). For other antibiotic classes, results were not significant. Using antibiotic class-specific cut-offs for positive reads of ARGs, a metagenomics approach potentially offers a culture-independent and more time-efficient manner to predict ABS for commonly prescribed antibiotic classes for sputum samples of adult people with CF. The use of metagenomics and artificial intelligence in clinical care will add to more personalized care for people with CF as well as better antibiotic stewardship. IMPORTANCE Damage induced by lung infections in people with cystic fibrosis (CF) is the leading factor to the mortality and morbidity of CF. To treat bacterial infections, people with CF are prescribed antibiotics. Routine antibiotic susceptibility (ABS) testing relies on culture-dependent, phenotypic techniques. These take several days up to more than a week, while timely intervention is key. To bridge this time gap, physicians in CF care use patient history of ABS data to start antibiotics, with risk of resistance to it. This pilot study explores a time saving alternative: the possibility to predict antibiotic resistance genes using shotgun metagenomics and artificial intelligence. By quicker prediction of ABS, people with CF can receive more adequate care, which results in the possible prevention of chronic infections and contributes to antibiotic stewardship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
- Innovations in Human Health and Life Sciences, Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Amsterdam Institute for Immunology and Infectious diseases, Infectious diseases, Amsterdam, the Netherlands.
- Amsterdam Public Health, Personalized Medicine, Amsterdam, the Netherlands.
- AIMMS Molecular Research Accelerator, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam UMC, Amsterdam, the Netherlands.
ORCID-Profile: Sonja van Scheijen, Anne H Neerincx, Els J M Weersink, Josje Altenburg, Christof Majoor, Jacqueline E van Muijlwijk-Koezen, Anke H Maitland-van der Zee, Mahmoud I Abdel-Aziz
Förderung
- Stichting TAAI
- Longfonds
- Stichting Astma Bestrijding
- Amsterdam Public Health Institute
- Health~Holland (LSH)
Zitieren
APA
van Scheijen, S., Neerincx, A. H., Weersink, E. J. M., Altenburg, J., Majoor, C., van Muijlwijk-Koezen, J. E., Maitland-van der Zee, A. H., Abdel-Aziz, M. I., & Amsterdam Mucociliary Clearance Disease Research Group (2025). Metagenomics approach to predict antibiotic resistance genes in sputum samples of adult people with cystic fibrosis: a pilot study. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02299-24
Vancouver
van Scheijen S, Neerincx AH, Weersink EJM, Altenburg J, Majoor C, van Muijlwijk-Koezen JE, et al. Metagenomics approach to predict antibiotic resistance genes in sputum samples of adult people with cystic fibrosis: a pilot study. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02299-24
BibTeX
@article{vanScheijen2025,
author = {van Scheijen, Sonja and Neerincx, Anne H and Weersink, Els J M and Altenburg, Josje and Majoor, Christof and van Muijlwijk-Koezen, Jacqueline E and Maitland-van der Zee, Anke H and Abdel-Aziz, Mahmoud I and Amsterdam Mucociliary Clearance Disease Research Group, Amsterdam Mucociliary Clearance Disease Research Group},
title = {Metagenomics approach to predict antibiotic resistance genes in sputum samples of adult people with cystic fibrosis: a pilot study},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.02299-24}
}
EUVIMED